Latest Distributions News

Atomo Diagnostics reports a robust Q2 FY25 with $1.2 million revenue driven by HIV self-test sales and a significant $2.44 million government grant for syphilis test development. The company advances its market footprint in Australia and New Zealand while maintaining a strong cash position.

Southern Cross Gold Consolidated has reported exceptional high-grade gold intersections from deep drilling at its Christina prospect, confirming robust mineralization extending 350 metres below previous hits and expanding the Sunday Creek project's footprint.

Barton Gold has confirmed significant high-grade silver alongside gold in its Tolmer gold system at the Tarcoola Project, prompting a new drilling campaign to explore the promising mineralisation further.

Austral Gold reported an 8.5% production increase in Q4 2024 alongside significant cost reductions, though full-year output fell short of forecasts due to equipment delays. The company sets ambitious 2025 targets, supported by a new toll processing deal and plant refurbishment financing.

AusQuest Limited has announced a significant porphyry copper-gold discovery at its Cangallo Project in Peru, marking a potential turning point ahead of an active 2025 exploration calendar. The company also secured $2.4 million in funding to advance drilling programs across its Peru and Australian assets.

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.

Credit Corp Group Limited has announced a fully franked ordinary dividend of AUD 0.32 per share for the six months ending December 2024, signaling steady shareholder returns.

LTR Pharma reports compelling clinical results for its nasal spray ED treatment SPONTAN®, demonstrating rapid absorption and strong safety, alongside strategic partnerships and a robust $34 million cash position.

MyEco Group Ltd has reported a robust 32% increase in sustainable product sales for Q2 FY25, driven by a remarkable 156% jump in MyEco branded product sales. Despite negative operating cash flow due to inventory build-up, the company is poised for continued growth in the second half of the fiscal year.

Lark Distilling Co. Ltd reported a 7% increase in net sales revenue for Q2FY25, driven by strong growth in direct-to-consumer, global travel retail, and export channels despite domestic B2B challenges. The company is advancing its brand restage and maintaining solid cash reserves.

Clever Culture Systems Ltd has achieved a key cashflow break-even milestone in Q4 2024, driven by strong sales growth from major pharmaceutical clients including AstraZeneca and Bristol Myers Squibb. The company is also advancing its product line with a new APAS® Contact Plate capability set for mid-2025 launch.

Sigma Healthcare has achieved unanimous shareholder approval for its proposed merger with Chemist Warehouse, marking a pivotal step toward reshaping Australia's pharmaceutical retail landscape. The merger now awaits final court approval, with implementation anticipated in mid-February 2025.